Zessly

Zessly (infliximab) is a biologic medication used to treat inflammatory conditions like rheumatoid arthritis and Crohn's disease. This intravenous infusion helps reduce inflammation and manage symptoms. Always consult a healthcare provider before use.

Infliximab, the active ingredient in Zessly, is prescribed to reduce inflammation and improve symptoms in autoimmune conditions. It is commonly used for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. Patients often ask, 'what is infliximab used for' due to its broad application in chronic inflammatory disorders.

Infliximab works by targeting specific proteins in the immune system to decrease inflammation. Many patients experience reduced joint pain and swelling with regular use. Some may notice improved mobility and fewer disease flare-ups over time.

Zessly should be administered under medical supervision due to the risk of infusion reactions. Patients with a history of infections or heart conditions should inform their healthcare provider. Regular monitoring may be required to assess treatment progress and safety.

Infliximab may interact with other immunosuppressants or live vaccines, potentially increasing infection risk. Combining it with certain medications, such as corticosteroids or methotrexate, is common but requires medical oversight. Always disclose all medications to your healthcare provider.